Aua Capital Management, LLC United Therapeutics Corp Transaction History

Aua Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$203.3 - $244.17 $1,016 - $1,220	-5 Reduced 14.29%	30 $6,000
Q2 2022 Aug 11, 2022	BUY	$174.81 - $241.14 $174 - $241	1 Added 2.94%	35 $8,000
Q1 2022 May 04, 2022	SELL	$166.16 - $213.96 $996 - $1,283	-6 Reduced 15.0%	34 $6,000
Q4 2021 Feb 11, 2022	SELL	$184.32 - $216.08 $368 - $432	-2 Reduced 4.76%	40 $9,000
Q3 2021 Nov 09, 2021	BUY	$179.86 - $214.88 $359 - $429	2 Added 5.0%	42 $8,000
Q2 2021 Jul 29, 2021	BUY	$170.47 - $211.93 $340 - $423	2 Added 5.26%	40 $7,000
Q1 2021 May 11, 2021	BUY	$153.94 - $174.85 $5,080 - $5,770	33 Added 660.0%	38 $6,000
Q4 2020 Feb 09, 2021	BUY	$101.87 - $151.79 $509 - $758	5 New	5 $1,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Aua Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aua Capital Management, LLC with notifications on news.